Thursday, September 10, 2026
The Cancer News

AN AUTHORITATIVE RESOURCE FOR EVERYTHING ABOUT CANCER

Ranjit Nair, MD

Ranjit Nair, MD

Associate Professor and Center Medical Director in the Department of Lymphoma/Myeloma

MD Anderson Cancer Center in Houston, Texas.

Published Articles (1)

Peripheral T-Cell Lymphoma in 2026: Reclassification, BV-CHP as Standard, and a Pipeline Finally Targeting Disease Biology

June 23, 2026

Peripheral T-cell lymphomas are among the most challenging malignancies in hematologic oncology.